Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew G Johnson

Showing results (51-60 of 104) with videos related to

Pageof 11
Sort By:
Mayo Clinic Proceedings|August 12, 2005
Association of heparin-dependent antibodies and adverse outcomes in hemodialysis patients: a population-based studyLourdes Pena de la Vega, Randal S Miller, Margaret M Benda, et al.
Journal of Patient Experience|January 22, 2026
From Barriers to Solutions: A Design Synthesis to Improve Video Visit Experience for Older AdultsLindsey M Philpot, Priya Ramar, Rachel E Canning, et al.
The New Phytologist|July 18, 2018
Bridging the micro- and macroevolutionary levels in phylogenomics: Hyb-Seq solves relationships from populations to species and aboveTamara Villaverde, Lisa Pokorny, Sanna Olsson, et al.
American Journal of Botany|July 22, 2021
Exploring Angiosperms353: An open, community toolkit for collaborative phylogenomic research on flowering plantsWilliam J Baker, Steven Dodsworth, Félix Forest, et al.
Infectious Diseases and Therapy|November 23, 2023
Virologic Outcomes with Molnupiravir in Non-hospitalized Adult Patients with COVID-19 from the Randomized, Placebo-Controlled MOVe-OUT TrialJulie M Strizki, Jay A Grobler, Nicholas Murgolo, et al.
Infectious Diseases and Therapy|April 25, 2024
Correction to: Virologic Outcomes with Molnupiravir in Nonhospitalized Adult Patients with COVID-19 from the Randomized, Placebo-Controlled MOVe-OUT TrialJulie M Strizki, Jay A Grobler, Nicholas Murgolo, et al.
Pediatric Pulmonology|May 19, 2020
Plasma pharmacokinetics of ceftolozane/tazobactam in pediatric patients with cystic fibrosisAntonio C Arrieta, Jocelyn Y Ang, Zufei Zhang, et al.
Virology|November 27, 2025
Erratum to "Impact of baseline humoral immunity on treatment outcomes with molnupiravir in the MOVe-OUT randomized, controlled trial" [Virology 613 (2026) 110710]Matthew G Johnson, Julie M Strizki, David W Hilbert, et al.
Journal of Clinical Pharmacology|October 6, 2022
Ceftolozane/Tazobactam Probability of Target Attainment in Patients With Hospital-Acquired or Ventilator-Associated Bacterial PneumoniaWei Gao, Yogesh T Patel, Zufei Zhang, et al.
Applications in Plant Sciences|August 2, 2021
Exploring Angiosperms353: Developing and applying a universal toolkit for flowering plant phylogenomicsAngela J McDonnell, William J Baker, Steven Dodsworth, et al.
Pageof 11

Showing results (51-60 of 104) with videos related to

Sort By:
Pageof 11
Mayo Clinic Proceedings|August 12, 2005
Association of heparin-dependent antibodies and adverse outcomes in hemodialysis patients: a population-based studyLourdes Pena de la Vega, Randal S Miller, Margaret M Benda, et al.
Journal of Patient Experience|January 22, 2026
From Barriers to Solutions: A Design Synthesis to Improve Video Visit Experience for Older AdultsLindsey M Philpot, Priya Ramar, Rachel E Canning, et al.
The New Phytologist|July 18, 2018
Bridging the micro- and macroevolutionary levels in phylogenomics: Hyb-Seq solves relationships from populations to species and aboveTamara Villaverde, Lisa Pokorny, Sanna Olsson, et al.
American Journal of Botany|July 22, 2021
Exploring Angiosperms353: An open, community toolkit for collaborative phylogenomic research on flowering plantsWilliam J Baker, Steven Dodsworth, Félix Forest, et al.
Infectious Diseases and Therapy|November 23, 2023
Virologic Outcomes with Molnupiravir in Non-hospitalized Adult Patients with COVID-19 from the Randomized, Placebo-Controlled MOVe-OUT TrialJulie M Strizki, Jay A Grobler, Nicholas Murgolo, et al.
Infectious Diseases and Therapy|April 25, 2024
Correction to: Virologic Outcomes with Molnupiravir in Nonhospitalized Adult Patients with COVID-19 from the Randomized, Placebo-Controlled MOVe-OUT TrialJulie M Strizki, Jay A Grobler, Nicholas Murgolo, et al.
Pediatric Pulmonology|May 19, 2020
Plasma pharmacokinetics of ceftolozane/tazobactam in pediatric patients with cystic fibrosisAntonio C Arrieta, Jocelyn Y Ang, Zufei Zhang, et al.
Virology|November 27, 2025
Erratum to "Impact of baseline humoral immunity on treatment outcomes with molnupiravir in the MOVe-OUT randomized, controlled trial" [Virology 613 (2026) 110710]Matthew G Johnson, Julie M Strizki, David W Hilbert, et al.
Journal of Clinical Pharmacology|October 6, 2022
Ceftolozane/Tazobactam Probability of Target Attainment in Patients With Hospital-Acquired or Ventilator-Associated Bacterial PneumoniaWei Gao, Yogesh T Patel, Zufei Zhang, et al.
Applications in Plant Sciences|August 2, 2021
Exploring Angiosperms353: Developing and applying a universal toolkit for flowering plant phylogenomicsAngela J McDonnell, William J Baker, Steven Dodsworth, et al.
Pageof 11